Zydus Wellness subsidiary receives GST demand of Rs 56.33 crore

Published On 2024-12-30 07:35 GMT   |   Update On 2024-12-30 07:35 GMT

Ahmedabad: Zydus Wellness Products Limited, a wholly owned subsidiary of Zydus Wellness, has received a GST demand of Rs 56.33 crores along with applicable interest and penalty from the tax authority.

The intimation alleged that GST was payable in relation to acquisition of intellectual property rights from Heinz Italia S.P.A. by Heinz India Private Limited, now merged with ZWPL.

"Zydus Wellness Products Limited (“ZWPL”), a wholly owned subsidiary company, has received an intimation from The Directorate General of Goods and Services Tax Intelligence, Surat Zonal Unit under section 74(5) of the Central Goods and Services Tax Act, 2017 (“the Act”) alleging GST demand of Rs 56.33 crores along with applicable interest and penalty," the Company stated in a filing.
"ZWPL believes that there is a strong merit in the case and ZWPL is evaluating the next steps based on detailed review of the intimation," the filing added.
The period covered by the order relates to preacquisition period prior to January 30, 2019.
Due to this order, there is no impact on financial, operation or other activities of the Company / ZWPL.
The impact will be limited to the final tax liability as may be ascertained alongwith interest and penalty, if any and is eligible for indemnification by Heinz Italia S.P.A.

Read also: Zydus Wellness registers 20 percent net sales growth in Q1

With the launch of India’s first zero calorie replacement of sugar, called Sugar Free, in 1988, Zydus Wellness began its journey as India’s consumer Wellness Company. Since then, the company grown into a larger business, spanning the entire wellness spectrum with seven power brands - Complan, Sugar Free, I'm lite, Glucon-D, Everyuth, Nycil and Nutralite.

Read also: Setback to Zydus Wellness, Delhi HC bars Consumer goods giant from using brand name Sugarlite

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News